Aaron S Kelly Selected Research

Pediatric Obesity

1/2021	Aversion to Off-label Prescribing in Clinical Pediatric Weight Management: The Quintessential Double Standard.
9/2019	Severe Obesity in the Pediatric Population: Current Concepts in Clinical Care.
1/2019	Precision medicine in adult and pediatric obesity: a clinical perspective.
1/2018	The Potential Role of Combination Pharmacotherapy to Improve Outcomes of Pediatric Obesity: A Case Report and Discussion.
1/2017	Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment.
1/2017	Pharmacotherapy in the Management of Pediatric Obesity.
1/2016	Glucagon-Like Peptide-1 Receptor Agonist Treatment for Pediatric Obesity.
1/2015	Topiramate for weight reduction in adolescents with severe obesity.
7/2013	The role of glucagon-like peptide-1 receptor agonists for the treatment of adolescent obesity.
4/2012	Hyperleptinemia and hypoadiponectinemia in extreme pediatric obesity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aaron S Kelly Research Topics

Disease

24	Obesity 01/2022 - 01/2006
17	Morbid Obesity 01/2022 - 04/2013
15	Weight Loss (Weight Reduction) 01/2022 - 07/2006
12	Pediatric Obesity 01/2021 - 07/2011
10	Insulin Resistance 07/2015 - 01/2006
9	Inflammation (Inflammations) 12/2016 - 12/2004
8	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2007
8	Overweight 01/2020 - 12/2004
6	Hypertension (High Blood Pressure) 01/2019 - 07/2007
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2006
4	Body Weight (Weight, Body) 01/2020 - 07/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2015 - 12/2010
2	Chronic Disease (Chronic Diseases) 01/2021 - 01/2018
2	Abdominal Obesity 01/2018 - 06/2012
2	Hyperemia 03/2016 - 06/2012
2	Glucose Intolerance 01/2016 - 06/2012
2	Heart Failure 09/2007 - 09/2006
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Atherosclerosis 01/2019
1	Mucopolysaccharidosis I (Hurler Syndrome) 01/2018
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2018
1	Malnutrition (Nutritional Deficiencies) 12/2016
1	Hypercapnia 03/2016
1	Prediabetic State (Prediabetes) 01/2016
1	Musculoskeletal Pain 01/2016
1	Cardiotoxicity 06/2014
1	Osteosarcoma (Osteogenic Sarcoma) 10/2013
1	Weight Gain 04/2012
1	Nausea 02/2012
1	Acanthosis Nigricans 01/2010
1	Dyslipidemias (Dyslipidemia) 09/2007
1	Rupture 09/2007
1	Disease Progression 09/2007

Drug/Important Bio-Agent (IBA)

11	Insulin (Novolin)FDA Link 01/2018 - 12/2004
11	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2006
8	LipidsIBA 01/2018 - 01/2006
6	Triglycerides (Triacylglycerol)IBA 01/2018 - 07/2006
6	C-Reactive ProteinIBA 10/2013 - 07/2007
5	CholesterolIBA 10/2013 - 07/2006
4	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 06/2012
4	Biological ProductsIBA 01/2022 - 11/2018
4	Exenatide (Byetta)FDA Link 01/2022 - 02/2012
4	oxidized low density lipoproteinIBA 06/2012 - 07/2007
4	AdipokinesIBA 04/2012 - 01/2006
3	Liraglutide FDA Link 01/2021 - 01/2020
3	Topiramate (Topamax)FDA LinkGeneric 01/2018 - 01/2015
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2013 - 06/2012
3	LeptinIBA 04/2012 - 05/2007
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2019 - 07/2013
2	Atorvastatin (Lipitor)FDA Link 01/2019 - 11/2006
2	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 07/2007
2	HDL CholesterolIBA 01/2018 - 01/2018
2	Xanthine OxidaseIBA 01/2016 - 04/2014
2	Fibrinogen (Factor I)FDA Link 10/2013 - 08/2012
2	ApolipoproteinsIBA 10/2013 - 08/2012
2	HDL LipoproteinsIBA 10/2013 - 08/2012
2	Lipoprotein(a)IBA 10/2013 - 08/2012
2	Hemoglobins (Hemoglobin)IBA 04/2013 - 07/2007
2	AdiponectinIBA 04/2012 - 07/2007
2	LDL CholesterolIBA 03/2012 - 07/2006
2	Carvedilol (Coreg)FDA LinkGeneric 02/2012 - 07/2007
2	Pharmaceutical PreparationsIBA 02/2012 - 09/2007
2	Interleukin-6 (Interleukin 6)IBA 07/2011 - 07/2007
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2007 - 07/2007
2	8-epi-prostaglandin F2alphaIBA 07/2007 - 05/2007
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	AndrogensIBA 01/2018
1	antineoplaston A10 (A 10)IBA 01/2018
1	Phentermine (Adipex-P)FDA LinkGeneric 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2016
1	Uric Acid (Urate)IBA 01/2016
1	AnthracyclinesIBA 06/2014
1	EnzymesIBA 04/2014
1	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2013
1	Biomarkers (Surrogate Marker)IBA 08/2012
1	Metformin (Glucophage)FDA LinkGeneric 06/2012
1	Lisinopril (Prinivil)FDA LinkGeneric 02/2012
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 02/2012
1	Glyburide (Glibenclamide)FDA LinkGeneric 11/2007
1	Rosiglitazone (Avandia)FDA Link 11/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007
1	Metoprolol (Toprol-XL)FDA LinkGeneric 07/2007
1	Nitroglycerin (Dynamite)FDA LinkGeneric 07/2007
1	Oxygen (Dioxygen)IBA 07/2007
1	ResistinIBA 07/2007
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 11/2006
1	Sildenafil Citrate (Viagra)FDA Link 11/2006
1	Quinapril (Accupril)FDA LinkGeneric 11/2006

Therapy/Procedure

20	Therapeutics 01/2022 - 09/2006
11	Bariatric Surgery 01/2021 - 10/2013
10	Drug Therapy (Chemotherapy) 01/2021 - 11/2015
4	Precision Medicine 01/2019 - 01/2017
2	Cell Transplantation 01/2018 - 07/2015
1	Aftercare (After-Treatment) 01/2019
1	Transplantation 01/2018
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2017
1	Diet Therapy (Therapy, Diet) 04/2008